INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 227 filers reported holding INSMED INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,116,220 | -77.3% | 16,660 | -92.7% | 0.05% | -83.2% |
| Q3 2022 | $4,920,000 | +51.8% | 228,410 | +39.0% | 0.27% | +58.4% |
| Q2 2022 | $3,241,000 | -18.3% | 164,350 | -2.6% | 0.17% | +1.2% |
| Q1 2022 | $3,965,000 | -44.3% | 168,720 | -19.3% | 0.17% | -33.2% |
| Q1 2021 | $7,122,000 | +4.7% | 209,103 | +2.4% | 0.26% | +0.4% |
| Q4 2020 | $6,800,000 | -14.4% | 204,268 | -17.4% | 0.26% | -18.0% |
| Q3 2020 | $7,944,000 | +42.4% | 247,168 | +22.0% | 0.31% | +28.0% |
| Q2 2020 | $5,579,000 | -23.3% | 202,575 | -28.7% | 0.24% | -12.9% |
| Q2 2019 | $7,278,000 | +0.8% | 284,297 | +14.5% | 0.28% | +2.6% |
| Q1 2019 | $7,221,000 | – | 248,402 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 955,462 | $24,460,000 | 13.75% |
| Foresite Capital Management IV, LLC | 1,561,185 | $39,966,000 | 11.30% |
| Asymmetry Capital Management, L.P. | 730,440 | $18,699,000 | 10.13% |
| NEXTHERA CAPITAL LP | 470,741 | $12,051,000 | 10.04% |
| Palo Alto Investors LP | 7,890,917 | $202,007,000 | 9.82% |
| Vivo Capital, LLC | 1,748,174 | $44,753,000 | 4.19% |
| ACUTA CAPITAL PARTNERS, LLC | 435,500 | $11,149,000 | 3.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $9,111,000 | 3.38% |
| Consonance Capital Management LP | 1,711,150 | $43,805,000 | 3.10% |
| Opus Point Partners Management, LLC | 26,936 | $690,000 | 1.02% |